Canopy Growth Corporation announced on Thursday that it has acquired Storz & Bickel in a €145 million ($220 million CAD) deal. LEAFLY’S STRAIN LIBRARY HAS ‘EM ALL
Explore the World’s Largest Strain Database
LEAFLY’S STRAIN LIBRARY HAS ‘EM ALL
“S&B quite literally invented the vaporizer market. They make the best performing, highest quality, and most respected products in the segment,” said Peter Popplewell, PhD., Chief Technology Officer, Canopy Growth.
Canopy has already kickstarted the development of advanced vaporizing devices ahead of the next wave of federally-regulated products in Canada. Leveraging Storz & Bickel‘s IP into the tech-heavy vaporizer designs already in progress will allow the Ontario-based cannabis company to introduce new products that“will set a new bar in terms of quality, functionality, and consumer safety” according to Popplewell.
The acquisition strengthens Canopy’s operations in Germany where the company imports medical cannabis to European markets including approximately 2,000 German pharmacies.
“Joining Canopy will enable S&B to take the next significant development step forward. Access to Canopy Growth’s extensive portfolio of test laboratories as well as pharmaceutical and medical-scientific know-how opens up entirely new product development opportunities,” said Jürgen Bickel, CEO, Storz & Bickel.